Zyngenia Completes $15 million Series A Financing Extension
Zyngenia Inc., a Gaithersburg, Md.-based biotherapeutics company that is developing antibody drugs, completed a $15 million Series A financing extension from New Enterprise Associates.
8 September 2010•3 mins read
